Cite

HARVARD Citation

    Simons, M. et al. (2021). Editorial: co‐morbid gastrointestinal conditions are an important consideration in IBS management. Alimentary pharmacology & therapeutics. 53 (10), pp. 1151-1152. [Online]. 
  
Back to record